Publications by authors named "Roberto Zarrabeitia"

22Publications

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.

Orphanet J Rare Dis 2019 02 4;14(1):28. Epub 2019 Feb 4.

VASCERN HHT Reference Center, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, and Vascular Sciences, National Heart and Lung Institute, Imperial College London, London, UK.

View Article and Find Full Text PDF
February 2019

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

Gastroenterol Hepatol 2017 Oct 11;40(8):538-580. Epub 2017 Jun 11.

Centro de Investigación Biomédica en Enfermedades Hepáticas y Digestivas, CIBERehd, Instituto de Salud Carlos III, España; Laboratorio de Hemodinámica Hepática, Servicio de Hepatología, Hospital Clínic, IDIBAPS, Barcelona, España. Electronic address:

View Article and Find Full Text PDF
October 2017

Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.

BMC Med Genet 2017 Feb 23;18(1):20. Epub 2017 Feb 23.

Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Ramiro de Maeztu 9, Madrid, 28040, Spain.

View Article and Find Full Text PDF
February 2017

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).

Health Qual Life Outcomes 2017 Jan 23;15(1):19. Epub 2017 Jan 23.

Department of Radiology, Hospital Universitario Marqués de Valdecilla and Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain.

View Article and Find Full Text PDF
January 2017

Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.

Thromb Haemost 2016 06 28;115(6):1167-77. Epub 2016 Jan 28.

Luisa M. Botella, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu, 9, Madrid, 28040 Spain, E-mail:

View Article and Find Full Text PDF
June 2016

Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1.

BMC Med Genet 2013 Nov 25;14:121. Epub 2013 Nov 25.

Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

View Article and Find Full Text PDF
November 2013

Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.

Thromb Haemost 2012 Jul 3;108(1):41-53. Epub 2012 May 3.

Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas and Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.

View Article and Find Full Text PDF
July 2012

[Rendu-Osler disease with hepatic involvement: first transplant in Spain].

Med Clin (Barc) 2010 Oct 4;135(12):552-5. Epub 2010 Jun 4.

Servicio de Medicina Interna, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

View Article and Find Full Text PDF
October 2010

[Hereditary hemorrhagic telangiectasia].

Med Clin (Barc) 2005 Apr;124(15):583-7

Servicio de Medicina Interna, Hospital Sierrallana, Torrelavega, Cantabria, Spain.

View Article and Find Full Text PDF
April 2005